KRYS Stock Price - Krystal Biotech, Inc. logo

KRYS Stock Price

Krystal Biotech, Inc.

$305.23
-$0.45(-0.15%)
50
Overall
65
Value
27
Tech
60
Quality
How is this score calculated?
Market Cap
$9.05B
Volume
110.28K
52W Range
$202.99 - $382.54
Target Price
$376.20

KRYS stock price is $305.23 (-0.15% on the day), giving Krystal Biotech, Inc. a market cap of $9.05B. Below are the price chart, the MarketXLS Rank, the company profile and the latest news.

KRYS Stock Overview

Price
$305.23
Previous close
$305.68
Open
$305.68
Market cap
$9.05B
P/E ratio
41.5
52-week range
$202.99 - $382.54
1-year price target
$376.20
Sector
Healthcare
Industry
Biotechnology
Exchange
Nasdaq
MarketXLS Rank
50

About Krystal Biotech, Inc.

Krystal Biotech, Inc., a commercial-stage biotechnology company, discovers, develops, manufactures, and commercializes genetic medicines to treat diseases with high unmet medical needs in the United States. The company commercializes VYJUVEK (beremagene geperpavec-svdt, or B-VEC) for the treatment of dystrophic epidermolysis bullosa (DEB). It also develops KB105, which is in Phase 1/2 clinical trials for treating patients with deficient autosomal recessive congenital ichthyosis; KB104 for treating netherton syndrome; KB407 that is in Phase 1 clinical trials for treating cystic fibrosis; KB707 that is in Phase 1/2 clinical trials for the treatment of anti-PD-1 relapsed/refractory; KB408, which is in Phase 1 clinical trials for treating Alpha-1 antitrypsin deficiency; and KB301 that is in Phase 2 clinical trials for treating aesthetic skin conditions, as well as in open label study with ophthalmic B-VEC for treating for ocular complications of deb. Krystal Biotech, Inc. was founded in 2016 and is headquartered in Pittsburgh, Pennsylvania.

ABCD
1SymbolPriceChangeVol
2KRYS$305.23-0.1%110.28K
3
4
5
6

Get Krystal Biotech, Inc. Data in Excel

Stream real-time data directly to your spreadsheets

BUY NOW
Stock data provided by MarketXLS.